Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Tyra Biosciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +1 vs. Q2 2022
- Shares held
- 35.7M
- −51.1K (−0.1%) vs. Q2 2022
- Total value
- $313.8M
- +$58.2M (+22.8%) vs. Q2 2022
- New holders
- 4
- 16 more added
- Sold out
- 3
- 16 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 168 | $2.22B |
| Q1 2026 | 164 | $2.52B |
| Q4 2025 | 133 | $1.49B |
| Q3 2025 | 116 | $778.4M |
| Q2 2025 | 121 | $541.5M |
| Q1 2025 | 117 | $499.5M |
| Q4 2024 | 113 | $675.8M |
| Q3 2024 | 95 | $1.11B |
| Q2 2024 | 79 | $748.6M |
| Q1 2024 | 77 | $768.4M |
| Q4 2023 | 62 | $495.2M |
| Q3 2023 | 59 | $502.1M |
| Q2 2023 | 59 | $616.7M |
| Q1 2023 | 51 | $573.0M |
| Q4 2022 | 46 | $267.8M |
| Q3 2022 | 49 | $313.8M |
| Q2 2022 | 48 | $255.6M |
| Q1 2022 | 46 | $386.6M |
| Q4 2021 | 45 | $494.2M |
| Q3 2021 | 26 | $456.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Tyra Biosciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 7,236,454 | $63.6M | 1.36% | 00.0% | Unchanged |
| Boxer Capital, LLC | 6,448,359 | $56.7M | 3.19% | 00.0% | Unchanged |
| Canaan Partners XI LLC | 4,409,991 | $38.8M | 15.63% | 00.0% | Unchanged |
| FMR LLC | 4,026,301 | $35.4M | 0.00% | +58,211+1.5% | Added |
| Nextech Invest AG | 2,518,582 | $22.1M | 7.15% | 00.0% | Unchanged |
| BVF Inc | 2,472,327 | $21.7M | 0.90% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 1,416,998 | $12.5M | 2.30% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,327,665 | $11.7M | 0.90% | −47,400−3.4% | Reduced |
| TCG Crossover Management, LLC | 945,707 | $8.31M | 2.49% | +49,289+5.5% | Added |
| Cormorant Asset Management, LP | 743,988 | $6.54M | 0.46% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 682,018 | $6.01M | 0.00% | −30,281−4.3% | Reduced |
| BlackRock Inc. | 622,098 | $5.47M | 0.00% | −8,757−1.4% | Reduced |
| Vanguard Group Inc | 599,953 | $5.27M | 0.00% | +8,844+1.5% | Added |
| Perceptive Advisors LLC | 494,403 | $4.35M | 0.13% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 247,450 | $2.17M | 0.00% | +22,039+9.8% | Added |
| Woodline Partners LP | 241,099 | $2.12M | 0.03% | −48,073−16.6% | Reduced |
| JPMorgan Chase & Co | 219,547 | $1.93M | 0.00% | −4,945−2.2% | Reduced |
| State Street Corp | 217,988 | $1.92M | 0.00% | +3,963+1.9% | Added |
| Sio Capital Management, LLC | 152,159 | $1.34M | 0.57% | 00.0% | Unchanged |
| Logos Global Management LP | 127,316 | $1.12M | 0.14% | −39,210−23.5% | Reduced |
| Northern Trust Corp | 103,808 | $912.0K | 0.00% | +674+0.7% | Added |
| Charles Schwab Investment Management Inc | 96,175 | $846.0K | 0.00% | +14,874+18.3% | Added |
| Wellington Management Group LLP | 85,182 | $748.0K | 0.00% | +30,318+55.3% | Added |
| Citadel Advisors LLC | 40,619 | $357.0K | 0.00% | −34,226−45.7% | Reduced |
| Bank of New York Mellon Corp | 39,250 | $345.0K | 0.00% | +7,339+23.0% | Added |
| D. E. Shaw & Co., Inc. | 34,886 | $307.0K | 0.00% | −21,168−37.8% | Reduced |
| Rhumbline Advisers | 20,633 | $181.0K | 0.00% | +3,348+19.4% | Added |
| LPL Financial LLC | 20,000 | $176.0K | 0.00% | −500−2.4% | Reduced |
| Nuveen Asset Management, LLC | 18,756 | $165.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 13,791 | $121.0K | 0.00% | −5,928−30.1% | Reduced |
| Morgan Stanley | 12,522 | $110.0K | 0.00% | −914−6.8% | Reduced |
| New York State Common Retirement Fund | 10,525 | $93.0K | 0.00% | +37+0.4% | Added |
| Sepio Capital, LP | 10,625 | $93.0K | 0.01% | +10,625 | New |
| Fishman Jay A Ltd | 10,500 | $92.3K | 0.01% | +10,500 | New |
| American International Group, Inc. | 6,231 | $55.0K | 0.00% | +89+1.4% | Added |
| California State Teachers Retirement System | 5,180 | $46.0K | 0.00% | −432−7.7% | Reduced |
| Deutsche Bank AG | 4,922 | $43.0K | 0.00% | −875−15.1% | Reduced |
| Tower Research Capital LLC (TRC) | 4,203 | $37.0K | 0.00% | +1,266+43.1% | Added |
| Amalgamated Bank | 1,621 | $14.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,405 | $12.0K | 0.00% | +444+46.2% | Added |
| Ameritas Investment Partners, Inc. | 940 | $8.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 556 | $5.00K | 0.00% | −102−15.5% | Reduced |
| Citigroup Inc | 200 | $2.00K | 0.00% | −734−78.6% | Reduced |
| Royal Bank of Canada | 160 | $1.00K | 0.00% | +86+116.2% | Added |
| The PNC Financial Services Group, Inc. | 58 | $1.00K | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 73 | $1.00K | 0.00% | +39+114.7% | Added |
| UBS Group AG | 91 | $1.00K | 0.00% | +91 | New |
| Wells Fargo & Company | 39 | $0 | 0.00% | −114−74.5% | Reduced |
| Ellevest, Inc. | 27 | $0 | 0.00% | +27 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,663−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −12,910−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |